Wu Li-Tzy, Zhu He, Mannelli Paolo, Swartz Marvin S
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA; Department of Medicine, Division of General Internal Medicine, Duke University Medical Center, Durham, NC, USA; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA; Center for Child and Family Policy, Sanford School of Public Policy, Duke University, Durham, NC, USA.
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA.
Drug Alcohol Depend. 2017 Aug 1;177:153-162. doi: 10.1016/j.drugalcdep.2017.03.037. Epub 2017 May 29.
The increase in cannabis potency may have treatment implications for cannabis use disorder (CUD). Given the reported increase in prevalence of cannabis use among adults, there is a need to understand substance use treatment needs for CUD.
We examined demographics and behavioral health indicators of adults aged ≥18 years that met criteria for past-year CUD (n=10,943) in the 2005-2013 National Surveys on Drug Use and Health. We determined prevalence and correlates of past-year treatment use for alcohol/drug, any drug, and cannabis use related problems, to inform treatment efforts for CUD.
The majority of adults with past-year CUD were young adults aged 18-25 or men, had low income, and did not attend college. Two-thirds of adults with CUD met criteria for cannabis dependence, which was comparatively common among younger adults, women, low-income or publicly insured adults, and college-educated adults. Nicotine dependence (40.92%) and alcohol (44.07%) or other drug use disorder (19.70%) were prevalent among adults with CUD. Overall, less than 13% of adults with CUD had received alcohol/drug use treatment the past year; only 7.8% received cannabis-specific treatment. There was no significant yearly variation in treatment use prevalence over 9 years. In particular, Asian-Americans, women, and college-educated adults underutilized cannabis-specific treatment.
This large sample of adults with CUD reveals pervasive underutilization of cannabis-related treatment, especially in women, married adults, and those with college education, despite a high proportion of comorbid behavioral health problems.
大麻效力的增加可能对大麻使用障碍（CUD）的治疗产生影响。鉴于报告显示成年人中使用大麻的患病率有所上升，有必要了解CUD的物质使用治疗需求。
我们在2005 - 2013年全国药物使用和健康调查中，研究了年龄≥18岁且符合过去一年CUD标准的成年人（n = 10,943）的人口统计学和行为健康指标。我们确定了过去一年酒精/药物、任何药物以及与大麻使用相关问题的治疗使用率及其相关因素，以为CUD的治疗工作提供参考。
过去一年患有CUD的成年人中，大多数是18 - 25岁的年轻人或男性，收入较低，未上过大学。三分之二的CUD成年人符合大麻依赖标准，这在年轻人、女性、低收入或有公共保险的成年人以及受过大学教育的成年人中相对常见。患有CUD的成年人中，尼古丁依赖（40.92%）、酒精（44.07%）或其他药物使用障碍（19.70%）较为普遍。总体而言，过去一年中不到13%的CUD成年人接受过酒精/药物使用治疗；只有7.8%接受过大麻特定治疗。9年中治疗使用率没有显著的年度变化。特别是，亚裔美国人、女性和受过大学教育的成年人未充分利用大麻特定治疗。
这个大量患有CUD的成年人样本显示，尽管存在高比例的共病行为健康问题，但大麻相关治疗的利用普遍不足，尤其是在女性、已婚成年人以及受过大学教育的人群中。
